Entering text into the input field will update the search result below

Liminal BioSciences gets Nasdaq notice on minimum bid price deficiency

Mar. 07, 2022 5:10 PM ETLMNLBy: Jessica Kuruthukulangara, SA News Editor1 Comment
  • Liminal BioSciences (NASDAQ:LMNL) received a written notice from the Nasdaq indicating that it is not in compliance with the minimum bid price requirement of $1/share.
  • In the event LMNL does not regain compliance by Aug. 31, the company may be eligible for

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.